1. Cai, Jialiang, Song, Lina, Zhang, Feng, Fan, Jia, Dai, Zhi. 2024. Targeting SRSF10 might inhibit M2 macrophage polarization and potentiate anti-PD-1 therapy in hepatocellular carcinoma. In Cancer communications (London, England), 44, 1231-1260. doi:10.1002/cac2.12607. https://pubmed.ncbi.nlm.nih.gov/39223929/
2. Xiao, Wen, Adhikari, Samir, Dahal, Ujwal, Zhao, Yong-Liang, Yang, Yun-Gui. 2016. Nuclear m(6)A Reader YTHDC1 Regulates mRNA Splicing. In Molecular cell, 61, 507-519. doi:10.1016/j.molcel.2016.01.012. https://pubmed.ncbi.nlm.nih.gov/26876937/
3. Liu, Wenbo, Lu, Xukun, Zhao, Zheng-Hui, Sun, Qing-Yuan, Liu, Jianqiao. 2022. SRSF10 is essential for progenitor spermatogonia expansion by regulating alternative splicing. In eLife, 11, . doi:10.7554/eLife.78211. https://pubmed.ncbi.nlm.nih.gov/36355419/
4. Liu, Xiaoming, Zheng, Yongqiang, Xiao, Mengqing, Liu, Zexian, Cao, Ke. 2022. SRSF10 stabilizes CDC25A by triggering exon 6 skipping to promote hepatocarcinogenesis. In Journal of experimental & clinical cancer research : CR, 41, 353. doi:10.1186/s13046-022-02558-0. https://pubmed.ncbi.nlm.nih.gov/36539837/
5. Luo, Xiangyuan, Zhang, Zerui, Li, Siwen, Huang, Wenjie, Xia, Limin. 2023. SRSF10 facilitates HCC growth and metastasis by suppressing CD8+T cell infiltration and targeting SRSF10 enhances anti-PD-L1 therapy. In International immunopharmacology, 127, 111376. doi:10.1016/j.intimp.2023.111376. https://pubmed.ncbi.nlm.nih.gov/38113691/
6. Frederiksen, Sabrina B, Holm, Lise L, Larsen, Martin R, Krainer, Adrian R, Andresen, Brage S. 2020. Identification of SRSF10 as a regulator of SMN2 ISS-N1. In Human mutation, 42, 246-260. doi:10.1002/humu.24149. https://pubmed.ncbi.nlm.nih.gov/33300159/
7. An, Wenzhe, Yang, Qingqing, Xi, Yunlan, Yu, Shizhu, Zhou, Xuexia. 2023. Identification of SRSF10 as a promising prognostic biomarker with functional significance among SRSFs for glioma. In Life sciences, 338, 122392. doi:10.1016/j.lfs.2023.122392. https://pubmed.ncbi.nlm.nih.gov/38160788/
智鼠故事 
